News
22h
Zacks Investment Research on MSN5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings EstimatesThe first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to ...
3d
Zacks Investment Research on MSNViatris Q1 Earnings Release: What's in Store for the Stock?Viatris VTRS, a global healthcare company, is scheduled to report first-quarter 2025 results on May 8, 2025. The Zacks ...
NASDAQ:DNLI opened at $12.74 on Friday. Denali Therapeutics has a twelve month low of $10.57 and a twelve month high of $33.33. The firm has a market capitalization of $1.85 billion, a price-to ...
Leveraging disentanglement optimization in NLI, our proposed a Directed NLI (DNLI) model demonstrates excellent performance compared to state-of-the-art baseline models in experiments on three widely ...
Norges Bank bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results